☆ 4.7 Meeting Abstract

5-Y update of the randomized phase III trial DAHANCA19: Primary (Chemo) RT ± zalutumumab in HNSCC

RADIOTHERAPY AND ONCOLOGY (2018)

Get Full Text
Add to Collection

Journal

RADIOTHERAPY AND ONCOLOGY
Volume 127, Issue -, Pages S137-S138

Publisher

ELSEVIER IRELAND LTD
DOI: 10.1016/S0167-8140(18)30581-4

Keywords

-

Categories

Oncology Radiology, Nuclear Medicine & Medical Imaging

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available
Webinars Posters Questions Hubs Funding Journals Papers Connect Collections Reviewers About Us FAQs Mobile App Privacy Policy Terms of Use
© Peeref 2019-2024. All rights reserved.